Glossary: German Glossary
Arzneimittelmarkt-Neuordnungsgesetz – AMNOG is the Act on the Reform of the Market for Medicinal Products. AMNOG aims to limit the cost of pharmaceuticals by the statutory health insurance funds.
- Gemeinsamer Bundesausschuss (G-BA)
Gemeinsamer Bundesausschuss – The Joint Federal Committee (G-BA) is authorised to set limitations on coverage. It is the highest decision-making body of the joint self-government of a second function of the G-BA is the definition of drugs, which are subject to fixed prices.
Association of Statutory Health Insurance Funds – being the central association of the health insurance funds at federal level in accordance with section 217 a of Book V of the German Social Code (SGB V).
The only class of medicines in the existing market that have been called by G-BA for assessment while this was possible.
The Institute for Quality and Efficiency in Health Care (IQWiG) is a German agency responsible for assessing the quality and efficiency of medical treatments, including drugs, non-drug interventions, diagnostic and screening methods, and treatment and disease management.
- Social Code Book V (SGB V)
German social code book, this section specialises in Health insurance.